baber/WOPTO huggingface dataset:
Patent DE-69412775-D1 (DE)
Inventor: ISLAM SHAH MOHAMMAD REZAUL
IPC: G06F11/10
Filed: 1994-12-14
Granted: 1998-10-01
Abstract: The present invention provides a technique for queuing commands on an input/output controller for a parity drive in a level 4 or level 5 redundant array of inexpensive disk drives, which responds to receipt of a write instruction with appended data by determining a logical block address of a data drive for the appended data and a logical block address of a parity drive for redundant data belonging to a destination stripe of the appended data. If a parity cache entry corresponds to the parity address, a cache hit is deemed to have occurred. Responsive to a cache hit, computation of replacement parity data for the stripe may be done from parity data in cache at a location given by the parity cache entry, data read from the data drive, and the appended data. The newly calculated parity data is then placed in cache. A command is then sent to an input/output controller for the drive where the parity data is located to write the replacement parity data. Serialization of access to the parity data is moved from the disk drive to cache memory, allowing command queuing to be used with the disk drive to preserve optimum available performance of the drive. <IMAGE>
Patent DE-69417554-D1 (DE)
Inventor: NYSTROEM JAN-ERIK
IPC: C07C277/08
Filed: 1994-06-01
Granted: 1999-05-06
Abstract: PCT No. PCT/SE94/00517 Sec. 371 Date Jun. 28, 1994 Sec. 102(e) Date Jun. 28, 1994 PCT Filed Jun. 1, 1994 PCT Pub. No. WO94/29269 PCT Pub. Date Dec. 22, 1994A process for the production of guanidino protected  omega -aminoalkyl guanidines comprising reacting a diamine selectively at one amino group with an alkoxycarbonyl or aralkoxycarbonyl protected electrophilic guanylation reagent. The process of the invention is general and may be performed efficiently in one step yielding a product with high purity and in useful yields. The invention further refers to some compounds that are novel per se and to some novel compounds useful in the process of the invention.
Patent DE-69424515-D1 (DE)
Inventor: KNUDSEN WILLIAM
IPC: H05B3/84
Filed: 1994-12-21
Granted: 2000-06-21
Abstract: An arrangement for heating upper (32) and lower (30) windshield wiper blades parked proximate the lower edge of a windshield (10) utilizes an electric heating grid placed against the inside surface of the windshield, substantially in alignment with the parked wiper blades. The electric heating grid (42,44,46) is comprised of a first wire (42) in alignment with the lower blade (30), an intermediate wire (44) and an upper wire (46) in alignment with the upper blade (32). The wires have opposite ends which are connected to busses that are disposed at the lower edge of the windshield, the busses having leads for connection to power circuitry. The power circuitry includes a climate control system having a switch which is rotatable to a defrost position. When the switch is rotated to the defrost position so that the climate control system defrosts the windshield, current flows through the grid. As long as the switch is in the defrost position, the current continues to flow. The power circuitry also includes a windshield wiper deicing switch which operates independently of the defrost switch. Associated with the windshield wiper deicing switch is a timer which opens the closed deicing switch after a selected interval of time. This arrangement provides an inexpensive reliable system for deicing windshield wiper blades because the wires are disposed on the windshield against the inside surface of the windshield.
Patent DE-69425320-D1 (DE)
Inventor: EISENBACH MICHAEL
IPC: C07K1/22
Filed: 1994-01-12
Granted: 2000-08-24
Abstract: The invention relates to chemotactic factors for human spermatozoa that are purifiable from human follicular fluid. The factors are of peptidic and hydrophilic nature. The first factor has a molecular size of about 13 kDa and, the other, an apparent molecular size smaller that 1.3 kDa, as determined by high pressure gel filtration, as shown in the figure. They are for use in procedures related to human fertilization, particularly artificial insemination, in vitro fertilization, micromanipulation and direct microinjection of sperm to oocytes.
Patent DE-69433400-D1 (DE)
Inventor: GRIEVE ROBERT B
IPC: C12P21/04
Filed: 1994-01-12
Granted: 2004-01-22
Abstract: The present invention relates to isolated parasitic helminth nucleic acid sequences capable of hybridizing, under stringent conditions, to at least a portion of D. immitis nucleic acid sequence p4 and/or to at least a portion of D. immitis nucleic acid sequence p22U; to isolated parasitic helminth proteins that are encoded by such parasitic helminth nucleic acid sequences and that are capable of selectively binding to at least one component of immune serum capable of inhibiting helminth development; and to antibodies raised against such isolated parasitic helminth proteins. The present invention also relates to therapeutic compositions comprising such isolated nucleic acid sequences, proteins and/or antibodies. The present invention also includes methods to produce and use such nucleic acids, proteins, antibodies and therapeutic compositions capable of protecting animals from parasitic helminth infection and, particularly, from heartworm infection.
Patent DE-69434277-D1 (DE)
Inventor: HUNT TRACY K
IPC: C07C67/54
Filed: 1994-08-01
Granted: 2005-03-24
Abstract: Starting from a mixture containing tocopherol, fats and/or fat derivatives, more particularly fatty acids, and optionally sterol and/or sterol derivatives, the free fatty acids present in the mixture are esterified with an alcohol. The mixture is then transesterified with an alcohol in the presence of a basic catalyst. After the transesterification, the excess lower alcohol is distilled off from the reaction mixture. The transesterification catalyst and the glycerol present, if any, are removed and the fatty acid alkyl ester is distilled off from the mixture. Distillation of fatty acid alkyl esters can be accomplished with a packed column in sequence with a wiped film evaporator. The simultaneous recovery of tocopherol and sterol is possible. Tocopherols and sterols can be separated by the crystallization of sterols from a blend of organic solvents.
Patent DE-69500239-D1 (DE)
Inventor: ADRIAENSSENS FRANK CORNELIUS M
IPC: F16H37/02
Filed: 1995-07-06
Granted: 1997-05-22
Abstract: Transmission unit for motor vehicles of the type which is provided with a continuously variable transmission (3), a reversing unit (2) and a number of clutches (16-18) to engage the reversing unit (2) in one or the other sense of rotation, whereby at least one of these clutches (16-18) is controlled by means of a hydraulic pressure unit (25), with a piston (27) which can be moved in a cylinder (28), whereby the sealing between the piston (27) and the cylinder (28) consists of an elastic sealing ring (32), characterized in that the piston (27) is provided with means to let hydraulic medium escape under the influence of the centrifugal force, whereby these means consist of at least one passage (43) in the above-mentioned sealing ring (32). <MATH>
Patent DE-69502288-D1 (DE)
Inventor: DAVIS JOHN
IPC: G01N30/26
Filed: 1995-10-03
Granted: 1998-06-04
Abstract: An access valve suitable for controlling fluid flow into and out of a chromatography column has a central axially movable probe with a head (71) acting as a spool valve in a barrel (6). Axial movement of the probe adjusts the valve between a fully open condition, in which both a first conduit (73) extending through the probe and a second conduit (51) defined around the probe are open to the column interior, a partly open condition in which a second sealing land (76) on the probe closes the second conduit (51), and a fully closed position in which both conduits are closed. The three positions are useful for packing and unpacking chromatography media into and from the column. In the closed condition of the valve, the first and second conduits (73, 51) communicate with one another so that the valve interior can be cleaned while the column is operating.
Patent DE-69504329-D1 (DE)
Inventor: BARABAS MIHALY
IPC: C07C251/48
Filed: 1995-05-04
Granted: 1998-10-01
Abstract: PCT No. PCT/HU95/00014 Sec. 371 Date Nov. 5, 1996 Sec. 102(e) Date Nov. 5, 1996 PCT Filed May 4, 1995 PCT Pub. No. WO95/30649 PCT Pub. Date Nov. 16, 1995Hydroximic acid derivatives possess anti-ischemic effects, and therefore, they are useful for treating ischemic states and diseases, such as myocardial ischemia (which may be induced by occlusion of coronary arteries). These derivatives include compounds of formula (I): wherein: X represents a halogen; Z represents an aromatic group, a pyridinyl group, a picolyl group, or a lutidyl group; and R represents an -A-N(R1)R2 group, wherein: R1 and R2 represent, independently from each other, hydrogen or an alkyl group; or R1 and R2, together with the adjacent nitrogen atom, form a 5- to 7-membered, saturated heterocyclic group optionally containing an additional nitrogen, oxygen, or sulfur atom, the heterocyclic group optionally being substituted by at least one alkyl group; and A represents a straight or branched chain alkylene group, as well as pharmaceutically acceptable acid addition salts thereof. The invention further relates to processes for preparing the above noted compounds, and pharmaceutical compositions containing these compounds or their pharmaceutically acceptable acid addition salts as an active ingredient. Additionally, the invention relates to intermediate compounds of formula II used in preparing the compounds of formula I. Formula II is as follows: In formula II, the variables Z and R have the same definitions provided above.
Patent DE-69505835-D1 (DE)
Inventor: CHERIF-CHEIKH ROLAND
IPC: A61M31/00
Filed: 1995-09-27
Granted: 1998-12-10
Abstract: An injection device for intramuscular or subcutaneous injection of solid or semi-solid medicaments is disclosed. The device includes main body member having a needle attached thereto. A protective sleeve covers the needle and retracts into the main body member when the device is pressed against the skin of a patient. A plunger with an attached rod maintains the medicament in the patient as the needle is withdrawn.
Patent DE-69508501-D1 (DE)
Inventor: CUMALI VINCENZO
IPC: G05G1/06
Filed: 1995-08-31
Granted: 1999-04-29
Abstract: The ballgrip includes:     a cap (1) having a shaped coupling surface (2); a body (3) of a ballgrip (4) which can be mounted onto the gearbox lever (5), having a coupling surface (6) which is shaped complementary to the surface (2) of the cap (1) which is designed to support said coupling surface, thus allowing the body (3) and cap (1) to define together the ballgrip (4); removable joining means (7) of the cap (1) to the body (3) which permit the mounting onto the same body (3) of a plurality of caps (1) including: a guide (9) undirectionally placed between the body (3) and cap (1) so as to allow the relevant tangential sliding of the coupling surfaces (2,6) when assembling the ballgrip (4); a reaction element (10) which can be coupled to the guide (9) so as to prevent the backward sliding of the cap (1) on the body (3) and keep the positioning during use of the gearbox lever (5).   <MATH>
Patent DE-69508949-D1 (DE)
Inventor: RYDBECK ANNA
IPC: C07C275/40
Filed: 1995-09-22
Granted: 1999-05-12
Abstract: The invention provides iodinated bis phenyl compounds, useful as X-ray contrast agents, of formula I (wherein each C6R5 moeity may be the same or different; each R denotes a hydrogen or iodine atom or a group M, two or three non-adjacent R groups on each C6R5 moiety denoting iodine atoms and one, two or three R groups on each C6R5 moiety denoting M groups; X denotes a group providing a 1, 2 or 3 atom chain linking the two C6R5 groups, preferably where X is or contains in the bridging chain a carbonyloxy group each C6R5 group being a triodophenyl group or a group in which each R is other than hydrogen; and each M is independently a non-ionic hydrophilic moiety, M preferably being a non-ionic hydrophilic moiety comprising a monohydroxy- or polyhydroxy-alkyl group) and isomers, especially stereoisomers and rotamers, thereof.
Patent DE-69521218-D1 (DE)
Inventor: MAEKITALO TAPIO
IPC: B65D30/24
Filed: 1995-11-10
Granted: 2001-07-12
Abstract: The invention concerns a hose-like blank (10) of a plastic material. On the inner face of the hose-like blank (10), there are electrically conductive areas (11), and on the outer face of the hose-like blank (10), there are electrically conductive areas (12). The electrically conductive areas (11, 12) have been brought into electrical contact by means of overlapping of the inner face and the outer face of the hose-like blank (10).
Patent DE-69523573-D1 (DE)
Inventor: NIELSEN JORGEN TAGE
IPC: A23L3/04
Filed: 1995-02-09
Granted: 2001-12-06
Abstract: PCT No. PCT/DK95/00062 Sec. 371 Date Aug. 16, 1996 Sec. 102(e) Date Aug. 16, 1996 PCT Filed Feb. 9, 1995 PCT Pub. No. WO95/22352 PCT Pub. Date Aug. 24, 1995The method and the apparatus according to the invention relate to pasteurization of products in a tunnel pasteurizer. In the application of heating systems comprising water/steam heat exchangers in the zones for heating of sprinkling water, the pipelines and the valves for controlling the water and the steam become very complex and vulnerable, and the number of analog valves for steam become equal to the number of heat exchangers as a minimum. Leakages in analog valves for steam are frequent after some time in operation. According to the invention this problem is eliminated in that hot water is taken out under low pressure from a heating source (7) comprising a heat-insulted storage tank and a shared source of heat, where the water is circulating constantly, said hot water being supplied in a controlled amount directly to each zone (14b, . . . , 14n), in which the products are to be heated, and the hot water in the unit being maintained at a temperature, which is substantially higher than the temperature of the sprinkling water in the zone having the highest temperature. A reduced consumption of peak energy after a failure of equipment has terminated as well as a faster reestablishment of the operational temperature are hereby achieved as compared to the methods known up to now.
Patent DE-69528119-D1 (DE)
Inventor: THOMSON JAMES
IPC: G01T1/20
Filed: 1995-06-08
Granted: 2002-10-17
Abstract: A scintillation counting system utilizing scintillator capsules for the detection of radioactive substances in a sample for analysis include a liquid scintillator core encapsulated within a shell. The liquid scintillator comprises a base component or components and one or more fluors. The base component preferably includes one or more aromatic solvents. The fluors useful in the liquid or gel scintillator include any of the organic fluors well-known in the scintillation counting art. The liquid or gel scintillator can also include a wavelength shifter (i.e. secondary fluors). Useful wavelength shifters are also well known in the scintillation counting art. Additionally, a other materials can be added to the scintillator capsules to modify the characteristics of the scintillator capsules, and the scintillator capsules can be used in a variety of scintillation counting applications. <MATH>
Patent DE-69529272-D1 (DE)
Inventor: HANAI NOBUO
IPC: A61K38/00
Filed: 1995-08-08
Granted: 2003-02-06
Abstract: This invention provides a monoclonal antibody which recognizes an epitope corresponding to amino acids 10 to 220, amino acids 221 to 297, or amino acids 469 to 662, counting from the N-terminus of a human Mx protein MxA, and specifically reacts with the human Mx protein by western blotting, immunoprecipitation or immunocyte staining, and a hybridoma which produces the antibody. The human Mx protein MxA monoclonal antibody of this invention can be used, for example, in the diagnosis of viral infection.
Patent DE-69529754-D1 (DE)
Inventor: DARKE PAUL L
IPC: C12N9/64
Filed: 1995-07-17
Granted: 2003-04-03
Abstract: A method of purifying proteases from the Herpes Simplex Virus 1 and 2 is taught. A precursor protease is cloned in a host cell and then separated from the cell culture using cation exchange chromatography. The resulting protease is subjected to autoprocessing conditions and an autolytic cleavage occurs, resulting in mature protease.
Patent DE-69606105-D1 (DE)
Inventor: PAJONK GERARD
IPC: C01B33/16
Filed: 1996-07-02
Granted: 2000-02-17
Abstract: Prepn. of monolithic silica aerogel comprises hydrolysing and polycondensing a mixt., contg. organic silicon and an organic solvent in an acidic medium to obtain a transparent gel substituting the organic solvent with liq. carbon dioxide and then removing the carbon dioxide under supercritical conditions where the organic solvent is ethylacetoacetate. Also claimed is a silica aerogel prepd. by the above process.
Patent DE-69608014-D1 (DE)
Inventor: RAIO STEVEN M
IPC: F16P3/00
Filed: 1996-02-22
Granted: 2000-06-08
Abstract: A breakaway engagement mechanism is provided for use in connection with a press (10) having a stationary first platen (12) and a vertically translatable second platen (14), engagable to a vertically translatable drive cylinder mechanism. The engagement mechanism (30) comprises a drive cylinder coupling shaft (32) for engaging a drive cylinder mechanism and extending vertically therefrom. A second platen coupling member (34) is mounted to the coupling shaft and engagable to the second platen (14). A spring member is further provided, having a first end connectable to the second platen (14), and a second end connectable to the coupling member (34), for resiliently holding the coupling member (34) to the second platen (14).
Patent DE-69608911-D1 (DE)
Inventor: SCHOENFELDT LARS
IPC: C08J9/28
Filed: 1996-12-18
Granted: 2000-07-20
Abstract: A method for preparing a non-fibrous porous material essentially consisting of one or more hydrophilic polymers and/or pharmaceutical medicaments comprising forming an aqueous solution, sol or gel comprising one or more hydrophilic polymers and/or pharmaceutical medicaments, freezing the solution, sol or gel and extracting the frozen water selectively using a hydrophilic organic solvent being miscible with water at a temperature below 5° C. at which temperature the solvent is not able to dissolve the frozen solutes, leaving the non-fibrous material in a solid, porous form.
Patent DE-69615984-D1 (DE)
Inventor: ISHIKAWA HIROMICHI
IPC: C07J63/00
Filed: 1996-11-15
Granted: 2001-11-22
Abstract: Ursolic acid or a pharmacologically acceptable salt is the active ingredient in a metastasis suppressory composition to be administered to patients per os or by injection.
Patent DE-69625284-D1 (DE)
Inventor: VECOVEN JACQUES H
IPC: C09K17/10
Filed: 1996-06-25
Granted: 2003-01-23
Abstract: Hydraulic binder is made up of in wt.%: 40-80 cement clinker; 15-25 quick or ordinary lime; and 3-12 cpd. of calcium sulphate (gypsum or anhydride).
Patent DE-69719993-D1 (DE)
Inventor: JULIEN WILLIAM E
IPC: A23L11/00
Filed: 1997-07-31
Granted: 2003-04-24
Abstract: A composition, and method of use, for controlling, reducing or preventing the growth of protozoal bacteria in the rumen of a ruminant comprising cell bodies of a facultative anaerobe selected from the group consisting of Corynebacterium cell bodies and Brevibacterium cell bodies or a mixture of Corynebacterium cell bodies and Brevibacterium cell bodies, glutamic acid fermentation solubles, corn fermentation solubles, glutamic acid fermentation solubles and corn fermentation solubles.
Patent DE-69724742-D1 (DE)
Inventor: BROWN DAVID R
IPC: G11C29/40
Filed: 1997-11-26
Granted: 2003-10-16
Abstract: A circuit for testing a memory cell array 100. The circuit includes a test circuit 104 coupled to the array and includes a data output line 106 and a failure signal output line 108. A shift register 110, which includes a plurality of latches, a clock signal input 114, and an output line 116, is connected to the failure signal output line of the test circuit. The circuit also includes a three-state output buffer driver 118, the buffer driver including a data input line, a failure signal input line, and a data output line. The failure signal line of the buffer driver is connected to the output line of the shift register 110. Upon detecting a defective memory cell in the array, the test circuit produces a failure signal on the failure signal output line 116 of the test circuit. The failure signal is then sent to the shift register 110 causing the buffer driver 118 to enter a high-impedance state in response to said failure signal. The shift register 110 comprises a number of latches in accordance with the desired latency variability of the system or test equipment using the test circuit. <IMAGE>
Patent DE-69726025-D1 (DE)
Inventor: PROESMANS RAPHAEL
IPC: G06V10/145
Filed: 1997-06-12
Granted: 2003-12-11
Abstract: Method for acquiring a three-dimensional shape or image of a scene, wherein a predetermined pattern of lines is projected onto the scene and the shape is acquired on the basis of relative distances between the lines and/or intersections of the lines of the pattern.
Patent DE-69728592-D1 (DE)
Inventor: ADAMS THOMAS COLE
IPC: B01D29/01
Filed: 1997-02-12
Granted: 2004-05-19
Abstract: A panel for a screen, said panel comprising a plurality of groups of perforations, each group comprising six generally equal triangular apertures (513, 514, 515) arranged with their apices facing a central portion (550), wherein the apices of two (514, 515) opposing ones of said triangular apertures are spaced apart further than the apices of opposed ones of the remaining triangular apertures (513, 513; 513, 513). <IMAGE>
Patent DE-69806813-D1 (DE)
Inventor: SINGH B
IPC: H01M4/58
Filed: 1998-11-02
Granted: 2002-08-29
Abstract: A metal hydride rechargeable cell is provided that discharges during a test discharge at a rate of 8 C to 18 C and a cell temperature of 0° C. where the voltage remains above 0.2 volts during the half of the discharge curve. The cell comprises a negative electrode of hydrogen storage alloy material having a particle size volume distribution whose d(50) value does not exceed 2(2Dht)½, where Dh is the hydrogen diffusion coefficient for the alloy at 0° C. and t is a time period from about 200 to about 450 seconds. A method of manufacturing the cell of the present invention involves an activation protocol comprising at least one formation cycle, a heat treating step, and a cycling step. This method avoids unnecessary processing of the metal alloy material prior to incorporation into the negative electrode.
Patent DE-69808794-D1 (DE)
Inventor: DYSON JAMES
IPC: A47L5/28
Filed: 1998-12-17
Granted: 2002-11-21
Abstract: The present invention relates to a vacuum cleaner (1) comprising a first casing (10) housing dust separation apparatus, a second casing (11) housing at least one filter (21, 23) or other component of the vacuum cleaner (1), a central spine (13) housing at least one conduit and forming part of an airflow path within the vacuum cleaner (1), the first and second casings (10, 11) lying generally parallel to one another and the central spine (13) lying at least partly between the first and second casings (10, 11). Such a construction provides a vacuum cleaner having a more compact profile which enables the vacuum cleaner to be used to clean areas where there is a height restriction, for example underneath furniture.